Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

BACKGROUND: Experience using post-transplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation (HSCT) from matched sibling donors (MSD) or unrelated donors (UD) is limited and with controversial results. The study aim was to evaluate PT-...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Hematol Oncol
Päätekijät: Ruggeri, Annalisa, Labopin, Myriam, Bacigalupo, Andrea, Afanasyev, Boris, Cornelissen, Jan J., Elmaagacli, Ahmet, Itälä-Remes, Maija, Blaise, Didier, Meijer, Ellen, Koc, Yener, Milpied, Noel, Schouten, Harry C., Kroeger, Nicolaus, Mohty, Mohamad, Nagler, Arnon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5855999/
https://ncbi.nlm.nih.gov/pubmed/29544522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0586-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia